CID 138620496

Lomedeucitinib

Structural Information

Molecular Formula
C18H20N6O4S
SMILES
[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=C(C=CC=N2)S(=O)(=O)C)NC(=O)[C@@H]3CC34CC4
InChI
InChI=1S/C18H20N6O4S/c1-19-17(26)14-11(21-15-12(29(2,27)28)4-3-7-20-15)8-13(23-24-14)22-16(25)10-9-18(10)5-6-18/h3-4,7-8,10H,5-6,9H2,1-2H3,(H,19,26)(H2,20,21,22,23,25)/t10-/m0/s1/i1D3
InChIKey
VWIVBQZLVAGLMH-ASGODXDTSA-N
Compound name
4-[(3-methylsulfonylpyridin-2-yl)amino]-6-[[(2R)-spiro[2.2]pentane-2-carbonyl]amino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

19
Patents

419.1455 Da
Monoisotopic Mass

0.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 420.15278 206.5
[M+Na]+ 442.13472 211.8
[M-H]- 418.13822 212.8
[M+NH4]+ 437.17932 204.3
[M+K]+ 458.10866 206.6
[M+H-H2O]+ 402.14276 200.0
[M+HCOO]- 464.14370 218.8
[M+CH3COO]- 478.15935 233.1
[M+Na-2H]- 440.12017 210.3
[M]+ 419.14495 212.2
[M]- 419.14605 212.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe